Alembic Pharmaceuticals informs about disclosure

03 Jul 2025 Evaluate

Alembic Pharmaceuticals has informed that Alembic Pharmaceuticals Inc., wholly owned subsidiary of the Company has acquired Utility Therapeutics. The disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the aforesaid acquisition is enclosed as Annexure – I.

The above information is a part of company’s filings submitted to BSE.



Alembic Pharma Share Price

763.55 -5.00 (-0.65%)
23-Jan-2026 13:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.00
Dr. Reddys Lab 1238.70
Cipla 1323.65
Zydus Lifesciences 884.50
Lupin 2141.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×